32.7 Long-Term Safety and Efficacy of Blonanserin Oral Tablet (DSP-5423) in Adolescents With Schizophrenia: A 52-Week, Multicenter, Open-Label, Extension Study
Journal of the American Academy of Child & Adolescent Psychiatry（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要